Altogether, the clinicopathologic and molecular findings supported the diagnosis of PMF (with CALR mutation) and subsequent occurrence of the BCR::ABL1 rearrangement, therefore, interpretable as the coexistence of a Ph-negative MPN with CML. This evidence concerns the gene CALR and chronic myelogenous leukemia, BCR-ABL1 positive.